1-17 of 17
Keywords: Treatment
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2022) 15 (3): 816–826.
Published Online: 26 September 2022
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Fibromatosis-like metaplastic carcinoma Treatment Pathology Prognosis Fibromatosis-like metaplastic carcinoma...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2022) 15 (1): 267–276.
Published Online: 18 March 2022
...Jie Li; Pengfei Sun; Li Ma; Xianhua Min; Binqiang Ye; Yao Zhang; Weiwei Ta; Jiyun Deng; Xiangrong Cao; Chi Dong Ewing sarcoma and primitive neuroectodermal tumors (ES/PNETs) are rare tumors that belong to a family of round-cell neuroectodermally derived tumors, and their optimal treatment remains...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2022) 15 (1): 176–186.
Published Online: 10 March 2022
... patients were free of recurrence. Unfortunately, 1 patient died from a progressive disease 6 months after RT. ENB is a rare locally aggressive tumor of the nasosinusal cavities. The first-line treatment for resectable tumors should include primary surgical resection with adjuvant RT. However, this tumor...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2022) 14 (3): 1761–1767.
Published Online: 13 December 2021
...Makoto Saito; Shihori Tsukamoto; Takashi Ishio; Emi Yokoyama; Koh Izumiyama; Akio Mori; Masanobu Morioka; Takeshi Kondo; Hirokazu Sugino The standard treatment for colorectal mucosa-associated lymphoid tissue (MALT) lymphoma has not yet been established due to the rarity of the disease. Here, we...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2022) 14 (3): 1359–1365.
Published Online: 21 September 2021
... to be related to hypercytokinemia, with interleukin (IL)-6 playing a pivotal role. Anti-IL-6 monoclonal antibody therapy is an effective treatment modality for iMCD, but to date, there is no clear guidance on treatment of TAFRO in the absence of definitive diagnosis of iMCD, leading to suboptimal management...
Journal Articles
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2018) 11 (3): 665–670.
Published Online: 23 October 2018
...Eunhyun Lee; Yong-Il Ji Neuroendocrine carcinoma of the cervix is rare, and prognosis is very poor. Because of its rarity, effective treatment of neuroendocrine carcinoma of the cervix has not been established. It has distinct patterns of metastasis, but can be successfully treated with radical...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2018) 11 (1): 212–215.
Published Online: 28 March 2018
...Yota Sato; Taku Fujimura; Yumi Kambayashi; Akira Hashimoto; Setsuya Aiba Bexarotene is a third-generation retinoid X receptor-selective retinoid that is widely used for the early treatment of advanced-stage cutaneous T-cell lymphomas. In this report, we describe a case of successful treatment...
Journal Articles
Case Rep Oncol (2016) 9 (1): 205–211.
Published Online: 01 April 2016
..., and a high Ki-67 proliferation rate. Because of the patient's weight and medical comorbidities, no further extensive diagnostic tests were performed to detect metastatic disease, and because of contraindications, no further medical treatment was provided. The patient subsequently died 1 month after diagnosis...
Journal Articles
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2013) 6 (1): 98–103.
Published Online: 19 February 2013
...Morten Ladekarl; Gerda Elisabeth Villadsen; Anne Roed Rudbeck; Øystein Aagenæs; Jens Erik Nielsen; Stephen Hamilton-Dutoit; Marianne Nordsmark This case describes the clinical course and treatment of a 17-year-old male patient with advanced hepatocellular carcinoma (HCC) arising in a non-cirrhotic...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2011) 4 (3): 531–533.
Published Online: 11 November 2011
...H. Boyle; S. Négrier Treatment of metastatic kidney cancer has changed dramatically in the past years with the use of VEGF-targeted therapies and mTOR inhibitors. However, resistance occurs. We report here two cases of patients who benefited, both on disease control and side effects, from...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2010) 3 (3): 310–314.
Published Online: 09 September 2010
... Oncology Associates, Hoag Cancer Center, bDepartment of Pathology, Hoag Memorial Hospital Presbyterian, and cDepartment of Radiology, Hoag Memorial Hospital, Newport Beach, Calif., USA Key Words Granulosa cell tumor · Sex cord stromal tumors · Diagnosis · Treatment Abstract Background: Granulosa cell...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2010) 3 (2): 268–271.
Published Online: 24 July 2010
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Trastuzumab Breast cancer Treatment Herceptin HER2 neu Case Rep Oncol 2010;3:268 271...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2009) 2 (3): 210–216.
Published Online: 14 November 2009
...Sema Rakıcı; Güzin Gönüllü; Ş.Bilge Gürsel; Levent Yıldız; İ.Koray Bayrak; İdris Yücel Primary mucinous cystadenocarcinoma (MCA) of the breast was first described by Koenig and Tavassoli in 1998. To our knowledge, only 9 cases of MCA of the breast have been reported. The optimal treatment of MCA...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2009) 2 (2): 150–156.
Published Online: 20 August 2009
... is very rare. Consequently, the manner and timing in which treatment should be provided is imprecise. In the present case, the risk for cardiac complications was high, but given the presence of a partial bowel obstruction and the need to diagnose the primary site of her metastatic malignancy, the decision...